Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
eXoZymes develops enzyme-based biomanufacturing solutions that use AI-enhanced, cell-free enzyme systems.
DIMERx operates as a biopharmaceutical company.
28bio is a neurotechnology company that develops brain-on-a-chip platform designed to capture neurological processes.
CUNY SPH delivers online graduate education that prepares students for success in all domains of public health.
Neuroene Therapeutics offers novel small molecule mitochondrial therapeutics for epilepsy, Parkinson's Disease, and mitochondrial disease.
7 Generation Games makes educational video games and the tools to develop them.
iQure Pharma is a global biotech company that develops new therapeutics for patients and physicians.
Artio Medical develops endovascular medical devices for the embolization of vessels, aneurysms, and other vascular structures.
Immunicom is a biotechnology company.
Support and development of SciDAP - next generation user-friendly universal data analysis platform for biologists and bioinformaticians
Fesarius Therapeutics is to develop engineered skin replacement products.
Virtuoso Surgical specializes in developing endoscopic robotic tools for minimally invasive surgery.
Hillhurst develops technologies enabling the therapeutic use of low-dose carbon monoxide.
Hesperos, Inc, is a leader in efforts to characterize an individual’s biology with human-on-a-chip microfluidic systems.
Nuravax develops and researches on vaccines, preventive solutions and treatment for neurodegenerative disorders.
Quiver Bioscience develops medicines for brain disorders using human disease models and advanced AI technologies.
Cellular Logistics specializes in a cellular biomaterial as a stand-alone therapeutic for cardiac and tissue vascularization applications.
Matter Bio operates as company focus on preserving genome integrity.
A medical device company with a non-invasive treatment for infected metallic implants in the body.
Psilera is a biotechnology company that develops treatments for neurological and psychiatric disorders.
Domus Diagnostics provides a care diagnostics platform that offers respiratory disease home testing services.
Insilica is a bioinformatics company.
Co-Diagnostics is a molecular diagnostics company that enhances the output of molecular diagnostic tests.
Hepatx is developing regenerative medicine solutions.
National Institutes of Health has invested in 491 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
National Institutes of Health's top investment sectors include Biotechnology, Health Care, Life Science, Pharmaceutical, Medical. The firm invests across 33 different industry categories.
Among tracked funding rounds, Artio Medical received $28.0M in a Series A round. National Institutes of Health's total known invested capital is $1.9B.
National Institutes of Health's average investment size is $4.9M across its portfolio of 491 companies.
Recent National Institutes of Health portfolio additions include eXoZymes, DIMERx, 28bio, CUNY Graduate School of Public Health and Health Policy(CUNY SPH), Neuroene Therapeutics. These companies were founded in 2020 or later.